Sort
24,576 grants matching “microbiome”
Elucidating Pathophysiological Mechanisms of Intestinal Inflammation
$307,844Mark S. Silverberg · Sinai Health System · U01 · FY2021 · DK
Core 1: Translational and Clinical Resource Core
$307,791Julian M. Mackay-Wiggan · Columbia University Health Sciences · P50 · FY2021 · AR
The influence of structural violence and individual behavior and health on the gut microbiome and colorectal cancer risk
$307,692Lisa Tussing-Humphreys · University Of Illinois At Chicago · U54 · FY2021 · MD
Collaborative Research: Understanding spatiotemporal dynamics of plant-soil feedbacks: Consequences for shrub-grass interactions in a dryland ecotone
$307,495Jennifer A Rudgers · University Of New Mexico · · FY2021 · BIO
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)
$307,238John C He · Baylor College Of Medicine · P01 · FY2017 · DK
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities
$307,062Hua Xie · Meharry Medical College · U54 · FY2017 · MD
Systems biology and the evolutionary dynamics in a synthetic microbial community
$306,989William Harcombe · University Of Minnesota · R01 · FY2017 · GM
ERC Einstein Rockefeller CUNY Center for AIDS Research
$306,936Joan Weinberger Berman · Albert Einstein College Of Medicine · P30 · FY2024 · AI
Live microbial therapeutics for enzyme replacement therapy against homocystinuria
$306,931Joseph Moeller Schinaman · Petri Bio Llc · R43 · FY2021 · HD
Intestinal Dysbiosis Exacerbates Inflammation after Cardiopulmonary Bypass in Congenital Heart Disease
$306,928Jeffrey Salomon · University Of Nebraska Medical Center · P20 · FY2025 · GM
Vertical Sleeve Gastrectomy for Treatment of NASH: a pilot randomized control
$306,902Sayeed Ikramuddin · University Of Minnesota · R01 · FY2023 · DK
High-content study to analyze the nutritional value of natural products for healthy aging
$306,793Sudip Mondal · Vivoverse, Llc · R43 · FY2025 · AT
Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma
$306,740Susan Veronica Lynch · Henry Ford Health System · P01 · FY2021 · AI
Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma
$306,740Susan Veronica Lynch · Henry Ford Health System · P01 · FY2022 · AI
Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma
$306,740Susan Veronica Lynch · Henry Ford Health System · P01 · FY2024 · AI
Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk
$306,664H. Rex Gaskins · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Adaptation to diet and its impact on the gut microbiome and genomic variation
$306,600Sarah A Tishkoff · University Of Pennsylvania · · FY2013 · SBE
Vaginal ring for sustained release of lactic acid to prevent bacterial vaginosis and associated health risks
$306,500Richard A Cone · Mucommune, Llc · R43 · FY2021 · AI
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$306,499Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI
Highly Acidifying Intravaginal Rings with Lactobacillus Probiotics to Treat Bacterial Vaginosis
$306,483Keiichiro Kushiro · Mucommune, Llc · R43 · FY2023 · AI
THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS
$306,482Ryan A Wilcox · University Of Michigan At Ann Arbor · R37 · FY2024 · CA
A Novel Small Molecule for the Treatment of Periodontitis
$306,463Neil A Fanger · Virtici, Llc · R43 · FY2022 · DE
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
$306,423Mark T Hamann · University Of Mississippi · R01 · FY2014 · AT
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
$306,422Mark T Hamann · University Of Mississippi · R01 · FY2013 · AT
A Novel Small Molecule for the Treatment of Periodontitis
$306,391Neil A Fanger · Virtici, Llc · R43 · FY2023 · DE